Results 141 to 150 of about 30,023 (217)

Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations

open access: yesTherapeutics and Clinical Risk Management, 2016
Luca Prosperini, Simona Pontecorvo Department of Neurology and Psychiatry, Sapienza University, Rome, Italy Abstract: Delayed-release dimethyl fumarate (DMF), also known as gastroresistant DMF, is the most recently approved oral disease-modifying ...
Prosperini L, Pontecorvo S
doaj  

Oncometabolite fumarate facilitates PD-L1 expression and immune evasion in clear cell renal cell carcinoma

open access: yesCell Death and Disease
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma (RCC), with a rising incidence worldwide. However, the mechanisms by which ccRCC evades immune surveillance remain incompletely understood.
Yi Gao   +8 more
doaj   +1 more source

Headache in radiologically isolated syndrome: a hint toward imminent conversion: a case report

open access: yesJournal of Medical Case Reports
Background Headaches are more prevalent in patients with multiple sclerosis compared with the general population. However, headaches are still considered a rare symptom of multiple sclerosis, especially when they appear as an initial symptom.
Masoud Etemadifar   +5 more
doaj   +1 more source

Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2

open access: diamond, 2019
Anahid Safari   +6 more
openalex   +1 more source

Is it time to target no evident disease activity (NEDA) in multiple sclerosis? [PDF]

open access: yes, 2015
Banwell   +25 more
core   +1 more source

Bijels as a Fluid Labyrinth for Drugs: The Effect of Nanoparticles on the Release Kinetics of Ethosuximide and Dimethyl Fumarate

open access: gold, 2022
Valeria Vanoli   +5 more
openalex   +1 more source

Dimethyl fumarate for treating Papillon–Lefèvre syndrome

open access: yesJAAD Case Reports, 2023
Abdullah Al-Omair, MD   +2 more
doaj   +1 more source

OC 55.2 Dimethyl Fumarate and 4-Octyl Itaconate are Anticoagulants that Suppress Tissue Factor in Macrophages Via Inhibition of Type I Interferon

open access: gold, 2023
T.J. RYAN   +17 more
openalex   +1 more source

Home - About - Disclaimer - Privacy